Task: Answer the multiple-choice question.
Question: Which drug exhibits a -21.232% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] Cc1ccc(CN2CCN(/N=C/c3ccc(C)s3)CC2)cc1
[b] Cc1ccc(SCc2nc3ncccn3c2Br)cc1
[c] Cc1ccc(S(=O)(=O)CCC(=O)OC(C)C(=O)N2CCc3ccccc32)cc1
Answer: c. Cc1ccc(S(=O)(=O)CCC(=O)OC(C)C(=O)N2CCc3ccccc32)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(S(=O)(=O)CCC(=O)OC(C)C(=O)N2CCc3ccccc32)cc1
Cc1ccc(S(=O)(=O)CCC(=O)OC(C)C(=O)N2CCc3ccccc32)cc1
[1-(2,3-dihydroindol-1-yl)-1-oxopropan-2-yl] 3-(4-methylphenyl)sulfonylpropanoate